Explore Tools Publish Peer Review CV+

/Camidanlumab tesirine for relapsed or refractory classic Hodgkin lymphoma: a phase 2 study

Articles (20)

About Privacy Terms

Copyright © 2026. AllSci Corp. All rights reserved.